1. Romidepsin exposure time points to indication-specific dosing1
Cell experiments and pharmacokinetic modelling suggest that romidepsin exposure duration, rather than high concentrations, consistently drives HIV latency reversal. The framework combines patient pharmacokinetics with clonal and primary-cell assays, including a hollow-fibre system, to question transferring oncology dosing directly into HIV studies. This abstract-only report supports a dosing hypothesis, not evidence of an HIV cure.1
2. Vancomycin model choice changes predictive performance2
A prospective study of 90 hospitalised adults found poor concordance between two Bayesian vancomycin implementations. Posterior predictions from the Rodvold model were more accurate than those from the Goti model, showing why software and model choice deserve local evaluation. The subscription abstract describes one centre and patients with normal renal function, limiting extrapolation to other populations.2
3. Infusion duration shapes mRNA nanoparticle tolerability in primates3
An unreviewed preprint follows a cationic mRNA lipid nanoparticle from mice into two non-human-primate studies. Extending infusion time prevented the reported transient complement activation, while a blood biomarker tracked signalling in healthy lung endothelium. The findings connect delivery kinetics with a measurable pharmacodynamic response; this repository-abstract report does not establish human safety or therapeutic benefit.3
4. DS5 standardises drug-screen data and response analysis4
The unreviewed DS5 preprint presents an open-source framework connecting immutable raw screening data, drug-name standardisation, dose-response analysis and treatment prioritisation. It reproduced response measures across more than 428,000 drug–cell-line pairs and assessed tumour-response ranking in a small retrospective dataset. This abstract-only report highlights reproducibility infrastructure; use in tumour-board discussions does not demonstrate improved patient outcomes.4
5. Temperature reshapes bacterial responses to antibiotics5
Experiments in Escherichia coli show that heat and cold responses can dominate transcription under simultaneous antibiotic exposure. RNA sequencing and flow cytometry connect this behaviour with changes in energy state and DNA organisation, alongside stronger efflux responses. The publisher-deposited abstract suggests temperature deserves attention in antibiotic-response experiments; it does not establish a clinical treatment strategy.5
References
Tompkins LAR, Poliseno A, Ward A, Browne EP, Gilbert C, Sykes C, Kashuba ADM, Cottrell ML. Empirical PK/PD Model for Differentiating Intrinsic Dosing Rules by Therapeutic Indication With Relevance for HIV-1 Latency Reversal. Clinical pharmacology and therapeutics; 2026; Peer-reviewed original research article. DOI: 10.1002/cpt.70488. Accessed 2026-09-29T16:19:41.395Z.
Source evidence and access
Original abstract and first-online metadata
Paraphrase: Exposure time consistently drove latency reversal in cellular models; clinical dosing targets may differ by indication.
Publisher-deposited original abstract and first-online metadata inspected through Crossref; publisher full text not accessed.
Al-Khirbash AS, Za'abi MA, Al-Maqbali JS, Harun SN, Sheikh Ghadzi SM. Evaluation of two model-based Bayesian approaches for vancomycin dosing in general hospitalized patients. Journal of pharmacokinetics and pharmacodynamics; 2026; Peer-reviewed original research article. DOI: 10.1007/s10928-026-10066-3. Accessed 2026-09-29T16:19:41.395Z.
Source evidence and access
Original abstract and first-online metadata
Paraphrase: The two implementations disagreed; posterior Rodvold predictions were more accurate in the studied cohort.
Original publisher abstract and first-online header inspected; subscription full text restricted.
Dunne, C. M.; Radloff, K.; Gkionis, L.; Kahwaji, N.; Hartl, N.; Keil, O.; Fischer, A.; Maass, G.; Santel, A.; Tondera, D.; Kaufmann, J. Translational Pharmacokinetics and Pharmacodynamics of a Cationic mRNA-Lipid Nanoparticle from Mice to Non-Human Primates. bioRxiv; 2026; Unreviewed preprint, version 1. DOI: 10.64898/2026.09.23.749423. Accessed 2026-09-29T16:19:41.395Z.
Source evidence and access
Repository abstract and version-one posting date via bioRxiv API
Paraphrase: Longer infusion avoided transient complement activation in the reported non-human-primate experiments.
Original bioRxiv repository abstract and posting metadata; abstract-only daily mention.
Yang, H.; Lubkowitz, J.; Marth, G.; Cheshier, S.; Yang, C.-H.; Welm, A.; Moos, P.; Huang, X.; Qiao, Y. DS5: An Open-Source Framework for Standardized High-Throughput Drug Screening Data Storage, Analysis, and Drug Prioritization. bioRxiv; 2026; Unreviewed preprint, version 1. DOI: 10.64898/2026.09.22.753533. Accessed 2026-09-29T16:19:41.395Z.
Source evidence and access
Repository abstract and version-one posting date via bioRxiv API
Paraphrase: DS5 standardized storage, processing and prioritization while recovering published benchmark response measures.
Original bioRxiv repository abstract and posting metadata; abstract-only daily mention.
Jagadeesan R, Arsh AM, Chauhan V, Dash S, Ravaria P, Ribeiro AS. Thermal Shifts Dominate Single-Gene Responses to Transcription-Targeting Antibiotics. Advanced science (Weinheim, Baden-Wurttemberg, Germany); 2026; Peer-reviewed original research article. DOI: 10.1002/advs.77965. Accessed 2026-09-29T16:19:41.395Z.
Source evidence and access
Original abstract and first-online metadata
Paraphrase: Temperature shifts dominated bacterial transcriptional responses under combined antibiotic stress.
Publisher-deposited original abstract and first-online metadata inspected through Crossref; publisher full text not accessed.
Publication record
Published 2026-09-29.
Sources, selection and claims were checked in an independent AI editorial review, followed by the AI editor's approval. This is not academic peer review.
- 2026-09-29 · Version 77a073d1 · Viewing this version